Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Case and Commentary Oct 2023 How to Draw on Narrative to Mitigate Ageism William Smith, MD, MBA, MPH, David Elkin, MD, MSL, and Art Walaszek, MD Ageism is so structurally integrated and normalized in US health care that it is generally unnoticed by many clinicians. AMA J Ethics. 2023;25(10):E745-750. doi: 10.1001/amajethics.2023.745.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Case and Commentary Oct 2023 How to Draw on Narrative to Mitigate Ageism William Smith, MD, MBA, MPH, David Elkin, MD, MSL, and Art Walaszek, MD Ageism is so structurally integrated and normalized in US health care that it is generally unnoticed by many clinicians. AMA J Ethics. 2023;25(10):E745-750. doi: 10.1001/amajethics.2023.745.